Clinical Trial Update: Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating adjuvant chemotherapy with or without cemiplimab and sequential hypofractionated radiotherapy in unfit or elderly pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Stage III NSCLC | Phase 2 | Status: RECRUITING